Drug Trial Radar · NCT06637371
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
21
Actual
Start
Oct 16, 2024
Primary completion
Apr 10, 2027
Study completion Apr 10, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Oct 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy participants and participants with mild-to-moderate asthma.
Conditions
- Asthma
Interventions
AMG 691Drug
Subcutaneous (SC) injection
PlaceboDrug
SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)Time frame: Up to approximately 11 months
Locations
21 sites in 5 countries. Site status is shown where the registry gives one.
Orange County Research Center
Lake Forest, California
Translational Clinical Research LLC
Aventura, Florida
Destiny Research Center
Palmetto Bay, Florida
ClinCept, LLC
Columbus, Georgia
Chesapeake Clinical Research Inc
White Marsh, Maryland
Brigham and Womens Hospital
Boston, Massachusetts
Mayflower Clinical
South Dartmouth, Massachusetts
Mayo Clinic
Rochester, Minnesota
Prism Research LLC dba Nucleus Network
Saint Paul, Minnesota
University of North Carolina Clinical and Translational Research Center
Chapel Hill, North Carolina
Monroe Biomedical Research
Monroe, North Carolina
North Carolina Clinical Research
Raleigh, North Carolina
Allergy Asthma and Clinical Research Center
Oklahoma City, Oklahoma
Monroe Biomedical Research
North Charleston, South Carolina
Endeavor Clinical Trials
San Antonio, Texas
Clinical Medical and Analytical eXellence CMAX
Adelaide, South Australia, Australia
Algemeen Ziekenhuis Sint Maarten-Emmaus vzw
Mechelen, Belgium
Winchester District Memorial Hospital
Winchester, Ontario, Canada
VPD Heart and Lung Research Institute
Cambridge, United Kingdom
Chelsea and Westminster Hospital
London, United Kingdom
The Medicines Evaluation Unit
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.